INDIANAPOLIS - As the prevalence of diabetes increases, Eli Lilly and Company is making strides to improve the availability of care to patients.
Lilly is increasing its insulin manufacturing capacity and adding two new insulin-cartridge-filling lines to the Indianapolis facility. Those cartridges can be used in insulin pens, which are growing in popularity.
Operations manager for filling, Lyle Fait, said the filling lines will pump 600 cartridge units a minute.
"With diabetes worldwide becoming almost epidemic in terms of the magnitude, this is the supply and demand that we are trying to meet in terms of keeping the global market supplied," Fait said.
Lilly is a global leader in the treatment of diabetes. The company introduced insulin as a treatment in 1923.
Officials said $400 million was being poured into the facilities, which will further Lilly’s pursuit of offering a full range of innovative options to diabetics.
National diabetes statistics show nearly 25.8 million people in the United States have diabetes. As many of seven million of those people are undiagnosed.
Police investigating shooting Tuesday morning
A person has been shot on the east side of Indianapolis.
Pre-trial meeting set for molestation suspect
A pre-trial conference is scheduled Tuesday morning for a man suspected of molesting a 4-year-old at a day care.
Cannabis church: No marijuana smoking planned
There will be no sanctioned marijuana use at Wednesday's meeting of the First Church of Cannabis.
State fair: Sweet corn vs. waffle sundaes & more
It’s time to make the ever-so-difficult decision of which dish should win the Signature Food Contest for the 2015 Indiana State Fair.
How will SCOTUS ruling impact religious freedom?
The historic decision to legalize same-sex marriage in all 50 states is sparking conversation in places of worship across central Indiana.